Erasca Inc. (ERAS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Erasca Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$15.12
−0.66% today
Market cap
$5.3B
Overall quality
45/100
Kronos AI 30-day
−13.5%
3 of 8 simulated paths end higher
Erasca Inc. (ERAS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $5.3B. It trades at $15.12, down 0.66% today. Its overall quality score is 45 out of 100, ranked against the whole US market. 7 analysts' average target of $24.14 implies +59.7% from today's price. Kronos AI's 30-day forecast is −13.5% (3 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $24.14 |
| Low – high | $20.00 – $33.00 |
| Analysts | 7 |
| Upside to average | +59.7% |
Kronos AI 30-day forecast
| Expected close | $13.17 (−13.5%) |
| Likely range | −23.6% … +17.9% |
| As of | 2026-10-27 |
3 of 8 simulated paths end higher.
Quality scores
| Profitability | 38 |
| Solvency | 48 |
| Growth | 49 |
| Overall | 45 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.